Management of HR+ HER2- Metastatic Breast Cancer
The management of hormone receptor-positive (HR+) HER2-negative metastatic breast cancer focuses on targeted therapies and systemic treatments. Endocrine therap...
The management of hormone receptor-positive (HR+) HER2-negative metastatic breast cancer focuses on targeted therapies and systemic treatments. Endocrine therap...
N/A
Improved Survival Rates: With effective treatment strategies, including endocrine therapy and targeted agents, many patients experience extended overall survival compared to historical data.
Enhanced Quality of Life: Targeted therapies often have fewer side effects than traditional chemotherapy, leading to better quality of life during treatment, with manageable symptoms and improved daily functioning.
Disease Stabilization: Many patients achieve disease stabilization or a partial response to treatment, allowing for prolonged periods without disease progression, which can be critical for maintaining life quality and personal goals.
Enroll Now
Students
54
language
English
Duration
01h 00mLevel
beginner
Expiry period
Lifetime
Certificate
Yes
Mahmoud Nouh
English
Certificate Course
54 Students
01h 00m
17 Courses
47 Reviews
